Ultrasound Prodedures Coupled to Improve Lung Cancer Care
James Knepler, MD, is using endobronchial ultrasound (EBUS) via the airway walls to examine the mediastinum (media-STY-num)the cavity containing the lungs and heart that lung cancer often spreads toin order to obtain biopsy tissue.
His collaborator Nathan Schmulewitz, MD, is heading a clinical trial that will couple EBUS with endoscopic ultrasound (EUS)which examines the mediastinum through the esophagus. The EBUS and EUS procedures will be done on the same day to improve the chances of locating the cancer. Both are performed on an outpatient basis.
According to the American Lung Association, lung cancer is the leading cancer killer in both men and women in the
Knepler, assistant professor of pulmonary medicine, and other UC colleagues are the only physicians performing EBUS in the region.
Before the introduction of EBUS, Knepler said doctors had to perform blind biopsies through the wall of the trachea using a small needle.
Now, we can actually see where the mass is and stick it the first time, he said. EBUS increases our yield and our accuracy.
Schmulewitz, assistant professor of digestive diseases, said coupling EBUS and EUS will help locate cancer in patients.
This study is important, he said. By the time most lung cancer is found, its often advanced to other areas of the body, and small tumors dont usually cause symptoms.
Schmulewitz said in many cases, cancer has spread to lymph nodes in the mediastinum by the time medical symptoms are recognized. Although some of these patients remain good candidates for surgical removal of tumors, most would not benefit from surgery unless the cancer can be shrunk with chemotherapy.
Once lung cancer spreads, the chances of curing the patient with surgery are slim, Schmulewitz explained.
Knepler said coupling the procedures will save people from having to undergo a surgical procedure called a mediastinoscopy to see inside the mediastinum.
Oftentimes we can make a diagnosis without a more invasive procedure, he said. We dont want someone to have to go to surgery if it isnt beneficial or necessary.
Schmulewitz said this will be the first study in the
We can possibly save patients a trip to the operating room if we find we cant cure them surgically, he said. We hope these combined technique will give us more accurate results.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.